Mitsubishi UFJ Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.5M Buy
111,785
+5,906
+6% +$1.93M 0.03% 410
2025
Q1
$28.6M Buy
105,879
+11,181
+12% +$3.02M 0.03% 437
2024
Q4
$22.2M Buy
94,698
+9,393
+11% +$2.2M 0.02% 479
2024
Q3
$23.5M Buy
85,305
+6,744
+9% +$1.85M 0.03% 450
2024
Q2
$19.1M Buy
78,561
+9,771
+14% +$2.37M 0.02% 453
2024
Q1
$10.3M Buy
68,790
+12,646
+23% +$1.89M 0.01% 536
2023
Q4
$10.7M Buy
56,144
+3,665
+7% +$699K 0.02% 501
2023
Q3
$9.29M Buy
52,479
+5,980
+13% +$1.06M 0.02% 500
2023
Q2
$8.83M Buy
46,499
+2,609
+6% +$496K 0.02% 509
2023
Q1
$8.79M Buy
43,890
+3,421
+8% +$685K 0.02% 494
2022
Q4
$9.45M Buy
40,469
+3,269
+9% +$764K 0.03% 452
2022
Q3
$7.45M Buy
37,200
+2,825
+8% +$565K 0.02% 470
2022
Q2
$5.01M Buy
34,375
+2,738
+9% +$399K 0.02% 542
2022
Q1
$5.17M Buy
31,637
+1,918
+6% +$313K 0.02% 567
2021
Q4
$5.17M Buy
29,719
+1,087
+4% +$189K 0.02% 580
2021
Q3
$5.41M Sell
28,632
-273
-0.9% -$51.5K 0.03% 550
2021
Q2
$4.9M Buy
28,905
+1,210
+4% +$205K 0.03% 565
2021
Q1
$3.91M Buy
27,695
+3,207
+13% +$453K 0.03% 568
2020
Q4
$3.18M Buy
24,488
+853
+4% +$111K 0.02% 551
2020
Q3
$3.44M Buy
23,635
+3,762
+19% +$548K 0.03% 462
2020
Q2
$2.94M Buy
19,873
+1,939
+11% +$287K 0.03% 437
2020
Q1
$1.95M Sell
17,934
-1,933
-10% -$210K 0.03% 460
2019
Q4
$2.3M Buy
19,867
+3,135
+19% +$363K 0.03% 499
2019
Q3
$1.35M Buy
16,732
+2,063
+14% +$166K 0.02% 556
2019
Q2
$1.06M Buy
14,669
+1,011
+7% +$73.3K 0.02% 621
2019
Q1
$1.28M Buy
13,658
+1,392
+11% +$130K 0.03% 510
2018
Q4
$898K Sell
12,266
-1,083
-8% -$79.3K 0.02% 555
2018
Q3
$1.17M Buy
13,349
+2,248
+20% +$197K 0.02% 563
2018
Q2
$1.09M Sell
11,101
-624
-5% -$61.4K 0.02% 560
2018
Q1
$1.4M Sell
11,725
-673
-5% -$80.1K 0.03% 485
2017
Q4
$1.67M Buy
12,398
+11,661
+1,582% +$1.57M 0.04% 469
2017
Q3
$87K Sell
737
-48
-6% -$5.67K ﹤0.01% 790
2017
Q2
$63K Sell
785
-45
-5% -$3.61K ﹤0.01% 803
2017
Q1
$43K Sell
830
-98
-11% -$5.08K ﹤0.01% 817
2016
Q4
$36K Sell
928
-11,024
-92% -$428K ﹤0.01% 819
2016
Q3
$810K Buy
11,952
+184
+2% +$12.5K 0.02% 610
2016
Q2
$653K Buy
11,768
+266
+2% +$14.8K 0.02% 639
2016
Q1
$722K Buy
11,502
+1,989
+21% +$125K 0.02% 608
2015
Q4
$896K Buy
9,513
+680
+8% +$64K 0.03% 554
2015
Q3
$710K Sell
8,833
-156
-2% -$12.5K 0.02% 593
2015
Q2
$1.08M Buy
+8,989
New +$1.08M 0.03% 524